Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 755

Sort by

Sort Order Select

Journal Articles

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies

Blood Adv (2025) 9 (24): 6314–6325.

https://doi.org/10.1182/bloodadvances.2025017084

Published: 2025

Includes: Supplemental data

Journal Articles

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major

Pooja Khandelwal, Azada Ibrahimova, Adam Lane, Michael Grimley, Stella M. Davies, Sonata Jodele

Blood Adv (2025) 9 (24): 6370–6379.

https://doi.org/10.1182/bloodadvances.2025017197

Published: 2025

Includes: Supplemental data

Journal Articles

Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation

Bhavna Bhasin-Chhabra, Tao Wang, John E. Levine, Shalini Shenoy, Miguel-Angel Perales, Asad Bashey, Hershel Raff, Wael Saber

Blood Adv (2025) 9 (24): 6394–6401.

https://doi.org/10.1182/bloodadvances.2025016655

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes with third-party virus-specific T cells after the use of single-antigen cell lines to predict HLA restriction

Jeremy D. Rubinstein, Giang Pham, Anusha Sridharan, Ruby Khoury, YunZu M. Wang, Zahra Hudda, Jamie Wilhelm, Daniel A. Lichtenstein, Daria Heyenbruch, Jose A. Cancelas, Stella M. Davies, Carolyn Lutzko, Michael S. Grimley

Blood Adv (2025) 9 (24): 6305–6313.

https://doi.org/10.1182/bloodadvances.2025017097

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant Recipients

Blood Adv bloodadvances.2025017393.

https://doi.org/10.1182/bloodadvances.2025017393

Published: 2025

Includes: Supplemental data

Journal Articles

Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report

Jessie L Alexander, Blachy J. Dávila Saldaña, Ruta Brazauskas, Sravya Gethika Dammalapati, Linda M Griffith, Ami J. Shah, Kristin A Shimano, Hans D Ochs, Jack Bleesing, Christen L Ebens, Malika Kapadia, Andrea Bauchat, Neena Kapoor, Joseph H. Oved, Hesham Eissa, Hannah Lust, Michael D. Keller, Hilary Haines, Shanmuganathan Chandrakasan, Julie-An M. Talano, Ahmad Rayes, Lisa M. Madden, Evan B. Shereck, Holly K Miller, Lisa R Forbes Satter, Caridad A. Martinez, Jacob Rozmus, Jeffrey J Bednarski, Lolie C Yu, Deepakbabu Chellapandian, Victor M. Aquino, Alan P Knutsen, Hey Chong, Ashley Chopek, Alfred P Gillio, Avni Joshi, Hemalatha G. Rangarajan, Theodore B Moore, Jeffrey R. Andolina, Kenneth DeSantes, Mark T Vander Lugt, Susan E Prockop, David Shyr, Kathleen E. Sullivan, Suhag H Parikh, Katja G. Weinacht, Troy R. Torgerson, Rebecca A Marsh, Christopher C Dvorak, Alice Y Chan, Elie Haddad, Jennifer Heimall, Michael A. Pulsipher, Jennifer W Leiding, Donald B. Kohn, Jennifer M Puck, Luigi D Notarangelo, David J Rawlings, Morton J Cowan, Aleksandra Petrovic, Sung-Yun Pai, Lauri M. Burroughs

Blood Adv bloodadvances.2025017662.

https://doi.org/10.1182/bloodadvances.2025017662

Published: 2025

Includes: Supplemental data

Journal Articles

Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group

Blood Adv (2025) 9 (23): 6141–6157.

https://doi.org/10.1182/bloodadvances.2025016915

Published: 2025

Journal Articles

Fludarabine dosing in the youngest children: safety first

Rick Admiraal, Shelby Barnett, Caroline A Lindemans, Alwin D. R. Huitema, Gareth Veal

Blood Adv bloodadvances.2025018108.

https://doi.org/10.1182/bloodadvances.2025018108

Published: 2025

Journal Articles

Harnessing virus-specific T cells: expanding therapeutic strategies across diverse populations

Navid Djassemi, Benjamin Hanisch, Cecilia Motta, Naseem Maghzian, Anant Vatsayan, Jessica R. Durkee-Shock, Michael D. Keller

Blood Adv (2025) 9 (23): 5965–5975.

https://doi.org/10.1182/bloodadvances.2024013727

Published: 2025

Includes: Supplemental data

Journal Articles

Reproducibility and repeatability of the Myoton to quantify sclerotic chronic graft-versus-host disease

Nosha Farhadfar, Najla El Jurdi, Kelsey Baker, Shramana Ghosh, Mongoljin Bat-Erdene, MPH, Heidi Chen, Ruchi Sahu, Rachel Weiss, Jerry Mi, Gabriela Desatnik, Lacey R. Williams, Eric R Tkaczyk, Stephanie J. Lee

Blood Adv bloodadvances.2025016648.

https://doi.org/10.1182/bloodadvances.2025016648

Published: 2025

Includes: Supplemental data

Journal Articles

CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study

Blood Adv bloodadvances.2025018340.

https://doi.org/10.1182/bloodadvances.2025018340

Published: 2025

Includes: Supplemental data

Journal Articles

Successful engraftment in myeloablative transplant with cadaveric marrow after sudden unavailability of living donor.

Sumithira Vasu, Sarah A Wall, Karilyn Larkin, Sagar Munjal, Marcos J de Lima, Gabriela Sanchez-Petitto

Blood Adv bloodadvances.2025018888.

https://doi.org/10.1182/bloodadvances.2025018888

Published: 2025

Journal Articles

Priapism before and after hematopoietic stem cell therapy in individuals with sickle cell disease

Jose A. Mejias-Figueroa, Santosh L. Saraf, Clifford M. Takemoto, Mark Rodeghier, Michael R. DeBaun

Blood Adv (2025) 9 (22): 5811–5813.

https://doi.org/10.1182/bloodadvances.2025017353

Published: 2025

Journal Articles

The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD

Blood Adv (2025) 9 (22): 5763–5773.

https://doi.org/10.1182/bloodadvances.2025017116

Published: 2025

Includes: Supplemental data

Journal Articles

No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse

Blood Adv bloodadvances.2025018139.

https://doi.org/10.1182/bloodadvances.2025018139

Published: 2025

Includes: Supplemental data

Journal Articles

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGVHD biomarkers

Teresa Caballero-Velázquez, Javier Delgado Serrano, Lucía López-Corral, Christelle Ferra-Coll, Clara Beatriz García-Calderón, David Valcárcel, Irene García-Cadenas, Estefanía Pérez López, María-José Jiménez Lorenzo, Francisco Manuel Martín-Domínguez, María de los Reyes Jiménez-León, Guillermo Orti, Virginia Escamilla Gómez, Cristina Blázquez-Goñi, Almudena Cabero Martínez, Henry Andrade Ruiz, Estefanía Menéndez-Pedregal, Fermín Sánchez-Guijo, José Antonio Pérez Simón

Blood Adv (2025) 9 (21): 5528–5538.

https://doi.org/10.1182/bloodadvances.2025016284

Published: 2025

Includes: Supplemental data

Journal Articles

Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study

Eugenio Galli, Roberta Di Blasi, Alice Di Rocco, Caterina Cristinelli, Ilaria Pansini, Côme Bommier, Alessandro Corrente, Ilenia De Bernardis, Marcello Viscovo, Stefan Hohaus, Anna Modoni, Federica Sorà, Patrizia Chiusolo, Maurizio Martelli, Simona Sica, Catherine Thieblemont

Blood Adv (2025) 9 (21): 5501–5509.

https://doi.org/10.1182/bloodadvances.2025017378

Published: 2025

Includes: Supplemental data

Journal Articles

Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-AML activity

Maxime Jullien, Enora Ferron, Catherine Willem, Gaelle David, Nolwenn Legrand, alix Duquesne, Simon Bouzy, Mathilde Bastien, Alice Garnier, Thierry Guillaume, Amandine Le Bourgeois, Sophie Vantyghem, Pierre Peterlin, Katia GAGNE, Patrice Chevallier, Christelle Retière

Blood Adv bloodadvances.2025017707.

https://doi.org/10.1182/bloodadvances.2025017707

Published: 2025

Includes: Supplemental data

Journal Articles

Antibiotic risk score for acute graft-versus-host disease

Armin Rashidi, Fei Gao

Blood Adv bloodadvances.2025018317.

https://doi.org/10.1182/bloodadvances.2025018317

Published: 2025

Includes: Supplemental data

Journal Articles

HLA vaccine effect in double cord blood transplant: a Chinese cohort

Chi Hang Wong, Wilson Y. K. Chan, Pamela P. W. Lee, Daniel K. L. Cheuk, Wing Leung

Blood Adv (2025) 9 (20): 5378–5379.

https://doi.org/10.1182/bloodadvances.2025017346

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major

Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation

Outcomes with third-party virus-specific T cells after the use of single-antigen cell lines to predict HLA restriction

Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant Recipients

Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report

Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group

Fludarabine dosing in the youngest children: safety first

Harnessing virus-specific T cells: expanding therapeutic strategies across diverse populations

Reproducibility and repeatability of the Myoton to quantify sclerotic chronic graft-versus-host disease

CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study

Successful engraftment in myeloablative transplant with cadaveric marrow after sudden unavailability of living donor.

Priapism before and after hematopoietic stem cell therapy in individuals with sickle cell disease

The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD

No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGVHD biomarkers

Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study

Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-AML activity

Antibiotic risk score for acute graft-versus-host disease

HLA vaccine effect in double cord blood transplant: a Chinese cohort

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only